Vutrisiran Market Report 2026
Download Free Sample Buy Now
Vutrisiran Market Global Report 2026 Market Report Infographic Image

Published : April 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Vutrisiran Market Report 2026

Global Outlook – By Drug Class (RNA Interference (RNAi) Therapeutics, GalNAc-Conjugated Nucleic Acid Drugs, Synthetic RNA-Based Therapeutics), By Route Of Administration (Injectable, Subcutaneous), By Patient Demographics (Adult, Geriatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Vutrisiran Market Overview

• Vutrisiran market size has reached to $0.67 billion in 2025

• Expected to grow to $1.18 billion in 2030 at a compound annual growth rate (CAGR) of 12%

• Growth Driver: Rising Research And Development (R&D) Investments Fuel Growth Of The Market

• Market Trend: Expansion Into Cardiomyopathy Through FDA Approval Drives Growth in the Vutrisiran Market

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Vutrisiran Market?

Vutrisiran is a small interfering RNA (siRNA) therapy for hereditary transthyretin-mediated (hATTR) amyloidosis. It silences the transthyretin (TTR) gene, reducing abnormal TTR protein deposits that cause polyneuropathy and organ damage. Vutrisiran helps slow disease progression and improve neurological function, mobility, and quality of life with a longer dosing interval.

The main types of drug classes for the vutrisiran are antisense oligonucleotide, nucleic acids, nucleotides, nucleosides, and others. Antisense oligonucleotides (ASOs) are synthetic short DNA or RNA molecules that target specific mRNA sequences to regulate gene expression. It is administered through various routes of administration, such as oral, injectable, and subcutaneous, for several patient demographics, including pediatric, adult, and geriatric. It is distributed through various distribution channels such as hospital pharmacies, retail pharmacies, online pharmacies, and others.

Vutrisiran Market Global Report 2026 Market Report bar graph

What Is The Vutrisiran Market Size and Share 2026?

The vutrisiran market size has grown rapidly in recent years. It will grow from $0.67 billion in 2025 to $0.75 billion in 2026 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to breakthrough siRNA approvals, unmet needs in hATTR amyloidosis, limitations of liver transplant options, expansion of orphan drug policies, improved genetic diagnosis.

What Is The Vutrisiran Market Growth Forecast?

The vutrisiran market size is expected to see rapid growth in the next few years. It will grow to $1.18 billion in 2030 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to growing rare disease awareness, expansion of rna therapeutics pipeline, rising adoption of long-acting therapies, increased genetic screening, growth in specialty care centers. Major trends in the forecast period include growing adoption of rna interference therapies, increased focus on rare genetic disorders, expansion of long-interval dosing treatments, rising demand for targeted amyloidosis therapies, increased use of subcutaneous rna drugs.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Vutrisiran Market Segmentation

1) By Drug Class: RNA Interference (RNAi) Therapeutics, GalNAc-Conjugated Nucleic Acid Drugs, Synthetic RNA-Based Therapeutics

2) By Route Of Administration: Injectable, Subcutaneous

3) By Patient Demographics: Adult, Geriatric

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

Subsegments:

1) By RNA Interference (RNAi) Therapeutics: Small Interfering RNA (siRNA) Drugs, Gene-Silencing RNA Therapies

2) By GalNAc-Conjugated Nucleic Acid Drugs: GalNAc-Conjugated siRNA Therapies, Hepatocyte-Targeted RNA Therapeutics

3) By Synthetic RNA-Based Therapeutics: Chemically Modified RNA Therapeutics, Long-Acting RNA Therapeutics

What Is The Driver Of The Vutrisiran Market?

The increasing investment in research and development is expected to propel the growth of the vutrisiran market going forward. Research and development refers to innovating and improving products, services, or processes through systematic investigation and experimentation. The increasing investment in research and development (R&D)is due to government initiatives and funding, growing healthcare and pharmaceutical needs, sustainability, and environmental concerns. Research and development funding allows pharmaceutical companies to conduct clinical trials, demonstrating the drug's long-term benefits and safety, leading to broader regulatory approvals. Additionally, RNA interference (RNAi) technology advancements improve the drug's precision, reducing side effects and increasing patient adoption. For instance, April 2025, Office for National Statistics, a UK-based government department, the UK government’s net spending on research and development (R&D) reached approximately US $22.9 billion (£17.4 billion) in 2023, up from around US $20.0 billion (£16.1 billion) in 2022. Therefore, the increasing investment in research and development is driving the growth of the vutrisiran.

Key Players In The Global Vutrisiran Market

Major companies operating in the vutrisiran market are Alnylam Pharmaceuticals Inc

Global Vutrisiran Market Trends and Insights

Major companies operating in the vutrisiran market are expanding its use into cardiomyopathy via regulatory approval, such as supplemental indication for ATTR CM, to broaden the patient base and maximize long-term value. A supplemental new drug application (sNDA) is a regulatory filing that extends an approved drug's use to new indications. For instance, in March 2025, Alnylam Pharmaceuticals, a US-based biotech company, received FDA approval for AMVUTTRA (vutrisiran) in adult patients with transthyretin amyloidosis cardiomyopathy (ATTR-CM), becoming the first RNAi therapeutic approved for both polyneuropathy and cardiomyopathy forms of the disease. Therefore, the extension into cardiomyopathy is a key trend driving growth in the vutrisiran market by increasing its clinical reach and patient access.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Vutrisiran Market?

In April 2024, Medison Pharma, an Israel-based pharmaceutical company, partnered with Alnylam Pharmaceuticals Inc. to expand the commercialization of RNAi therapeutics. The partnership aims to enhance global access to Alnylam's groundbreaking RNAi therapies, especially for patients with rare diseases, by utilizing Medison's integrated commercialization platform across various regions, including LATAM, APAC, and other international markets. Alnylam Pharmaceuticals, Inc. is a US-based pharmaceutical company that manufactures vutrisiran.

Regional Insights

North America was the largest region in the vutrisiran market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Vutrisiran Market?

The vutrisiran market consists of sales of pre-filled syringes and vials for subcutaneous injection. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Vutrisiran Market Report 2026?

The vutrisiran market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the vutrisiran industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Vutrisiran Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $0.75 billion
Revenue Forecast In 2035 $1.18 billion
Growth Rate CAGR of 12.1% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Drug Class, Route Of Administration, Patient Demographics, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Alnylam Pharmaceuticals Inc
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Vutrisiran Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Vutrisiran Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Vutrisiran Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Vutrisiran Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Growing Adoption Of Rna Interference Therapies

4.2.2 Increased Focus On Rare Genetic Disorders

4.2.3 Expansion Of Long-Interval Dosing Treatments

4.2.4 Rising Demand For Targeted Amyloidosis Therapies

4.2.5 Increased Use Of Subcutaneous Rna Drugs

5. Vutrisiran Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Genetic Disorder Centers

5.4 Retail Pharmacies

5.5 Homecare Patients

6. Vutrisiran Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Vutrisiran Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Vutrisiran PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Vutrisiran Market Size, Comparisons And Growth Rate Analysis

7.3. Global Vutrisiran Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Vutrisiran Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Vutrisiran Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Vutrisiran Market Segmentation

9.1. Global Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

RNA Interference (RNAi) Therapeutics, GalNAc-Conjugated Nucleic Acid Drugs, Synthetic RNA-Based Therapeutics

9.2. Global Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Injectable, Subcutaneous

9.3. Global Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adult, Geriatric

9.4. Global Vutrisiran Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

9.5. Global Vutrisiran Market, Sub-Segmentation Of RNA Interference (RNAi) Therapeutics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Small Interfering RNA (siRNA) Drugs, Gene-Silencing RNA Therapies

9.6. Global Vutrisiran Market, Sub-Segmentation Of GalNAc-Conjugated Nucleic Acid Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

GalNAc-Conjugated siRNA Therapies, Hepatocyte-Targeted RNA Therapeutics

9.7. Global Vutrisiran Market, Sub-Segmentation Of Synthetic RNA-Based Therapeutics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chemically Modified RNA Therapeutics, Long-Acting RNA Therapeutics

10. Vutrisiran Market Regional And Country Analysis

10.1. Global Vutrisiran Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Vutrisiran Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Vutrisiran Market

11.1. Asia-Pacific Vutrisiran Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Vutrisiran Market

12.1. China Vutrisiran Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Vutrisiran Market

13.1. India Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Vutrisiran Market

14.1. Japan Vutrisiran Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Vutrisiran Market

15.1. Australia Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Vutrisiran Market

16.1. Indonesia Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Vutrisiran Market

17.1. South Korea Vutrisiran Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Vutrisiran Market

18.1. Taiwan Vutrisiran Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Vutrisiran Market

19.1. South East Asia Vutrisiran Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Vutrisiran Market

20.1. Western Europe Vutrisiran Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Vutrisiran Market

21.1. UK Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Vutrisiran Market

22.1. Germany Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Vutrisiran Market

23.1. France Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Vutrisiran Market

24.1. Italy Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Vutrisiran Market

25.1. Spain Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Vutrisiran Market

26.1. Eastern Europe Vutrisiran Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Vutrisiran Market

27.1. Russia Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Vutrisiran Market

28.1. North America Vutrisiran Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Vutrisiran Market

29.1. USA Vutrisiran Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Vutrisiran Market

30.1. Canada Vutrisiran Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Vutrisiran Market

31.1. South America Vutrisiran Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Vutrisiran Market

32.1. Brazil Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Vutrisiran Market

33.1. Middle East Vutrisiran Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Vutrisiran Market

34.1. Africa Vutrisiran Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Vutrisiran Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Vutrisiran Market Regulatory and Investment Landscape

36. Vutrisiran Market Competitive Landscape And Company Profiles

36.1. Vutrisiran Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Vutrisiran Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Vutrisiran Market Company Profiles

36.3.1. Alnylam Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Global Vutrisiran Market Competitive Benchmarking And Dashboard

38. Key Mergers And Acquisitions In The Vutrisiran Market

39. Vutrisiran Market High Potential Countries, Segments and Strategies

39.1 Vutrisiran Market In 2030 - Countries Offering Most New Opportunities

39.2 Vutrisiran Market In 2030 - Segments Offering Most New Opportunities

39.3 Vutrisiran Market In 2030 - Growth Strategies

39.3.1 Market Trend Based Strategies

39.3.2 Competitor Strategies

40. Appendix

40.1. Abbreviations

40.2. Currencies

40.3. Historic And Forecast Inflation Rates

40.4. Research Inquiries

40.5. The Business Research Company

40.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Vutrisiran Market, Overview Of Key Products - Product Examples
  • Table 2: Global Vutrisiran Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Vutrisiran Market, Supply Chain Analysis
  • Table 4: Global Vutrisiran Market, Major Raw Material Providers
  • Table 5: Global Vutrisiran Market, Major Resource Providers
  • Table 6: Global Vutrisiran Market, Major Manufacturers (Suppliers)
  • Table 7: Global Vutrisiran Market, Major Distributors And Channel Partners
  • Table 8: Global Vutrisiran Market, Key Technologies & Future Trends
  • Table 9: Global Vutrisiran Market, Major Trends
  • Table 10: Global Vutrisiran Market, Major End Users
  • Table 11: Global Vutrisiran Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Vutrisiran Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Vutrisiran Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Vutrisiran Market - TAM, US$ Billion, 2025
  • Table 15: Global Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Vutrisiran Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Vutrisiran Market, Sub-Segmentation Of RNA Interference (RNAi) Therapeutics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Vutrisiran Market, Sub-Segmentation Of GalNAc-Conjugated Nucleic Acid Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Vutrisiran Market, Sub-Segmentation Of Synthetic RNA-Based Therapeutics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Vutrisiran Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Vutrisiran Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Vutrisiran Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Vutrisiran Market - Company Scoring Matrix
  • Table 98: Alnylam Pharmaceuticals Inc. Financial Performance
  • Table 99: Global Vutrisiran Market, Competitive Benchmarking (In USD Billions)
  • Table 100: Global Vutrisiran Market, Competitive Dashboard
  • Table 101: Global Vutrisiran Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 102: Global, Vutrisiran Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Table 103: Global, Vutrisiran Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Table 104: Global, Vutrisiran Market Size Gain ($ Billion), Segmentation By Patient Demographics, 2025 – 2030

List Of Figures

    Figure 1: Global Vutrisiran Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Vutrisiran Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Vutrisiran Market, Supply Chain Analysis
  • Figure 4: Global Vutrisiran Market, Major Raw Material Providers
  • Figure 5: Global Vutrisiran Market, Major Resource Providers
  • Figure 6: Global Vutrisiran Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Vutrisiran Market, Major Distributors And Channel Partners
  • Figure 8: Global Vutrisiran Market, Key Technologies & Future Trends
  • Figure 9: Global Vutrisiran Market, Major Trends
  • Figure 10: Global Vutrisiran Market, Major End Users
  • Figure 11: Global Vutrisiran Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Vutrisiran Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Vutrisiran Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Vutrisiran Market - TAM, US$ Billion, 2025
  • Figure 15: Global Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Vutrisiran Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Vutrisiran Market, Sub-Segmentation Of RNA Interference (RNAi) Therapeutics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Vutrisiran Market, Sub-Segmentation Of GalNAc-Conjugated Nucleic Acid Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Vutrisiran Market, Sub-Segmentation Of Synthetic RNA-Based Therapeutics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Vutrisiran Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Vutrisiran Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Vutrisiran Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Vutrisiran Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Vutrisiran Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Vutrisiran Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Vutrisiran Market - Company Scoring Matrix
  • Figure 98: Alnylam Pharmaceuticals Inc. Financial Performance
  • Figure 99: Global Vutrisiran Market, Competitive Benchmarking (In USD Billions)
  • Figure 100: Global Vutrisiran Market, Competitive Dashboard
  • Figure 101: Global Vutrisiran Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 102: Global, Vutrisiran Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Figure 103: Global, Vutrisiran Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Figure 104: Global, Vutrisiran Market Size Gain ($ Billion), Segmentation By Patient Demographics, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Vulvodynia Treatment Market Report 2026 - Global Outlook – By Drug Type (Anticonvulsants, Tricyclic Antidepressants, Local Anesthetics, Antimicrobials, Hormone Creams, Nerve Blocks, Other Drug Types), By Route Of Adminis...

Vasopressin Market Report 2026 - Global Outlook – By Product Type (Intravenous Injection, Intramuscular Injection, Subcutaneous Injection), By Application (Anti-Diuretic Hormone Deficiency, Vasodilatory Shock, Gastrointe...

Vasodilators Market Report 2026 - Global Outlook – By Type (Arterial Dilators, Venous Dilators, Mixed Dilators), By Drugs (Nitroglycerin, Alprostadil, Minoxidil, Sorbitrate, Other Drugs), By Indication (Hypertension, Ang...

Vetronics Market Report 2026 - Global Outlook – By Vehicle Type ( Main Battle Tank, Light Combat Vehicles, Armored Personnel Carriers, Infantry Fighting Vehicle, Other Vehicles), By System ( Weapon And Control System, Co...

Varenicline Market Report 2026 - Global Outlook – By Type (0.5 Mg Tablets, 1 Mg Tablets), By Route Of Administration (Oral, Sublingual, Transdermal), By Patient Type (Smokers, Ex Smokers, Pre Quitters), By Application (H...

Argon Market Report 2026 - Global Outlook – By Type (Liquid, Gas ), By Function (By Function (Shielding Or Inerting, Welding and Metal Processing, Blanketing and Purging, Leak Detection and Tracing, Insulation), By End U...

Caviar Market Report 2026 - Global Outlook – By Product (Sevruga, Osetra, Salmon, Sushi, Beluga, Sterlet, Other Products), By Form (Fresh, Dried, Frozen), By Sales Channel (On-Trade, Off-Trade), By Application (Hotels An...

Ferro Manganese Market Report 2026 - Global Outlook – By Production Methods (Carbothermic Reduction (Blast Furnace), Submerged Arc Furnace (SAF) Process, Electric Arc Furnace (EAF) Process, Silicothermic Reduction Proces...

Frequently Asked Questions

The Vutrisiran market was valued at $0.67 billion in 2025, increased to $0.75 billion in 2026, and is projected to reach $1.18 billion by 2030.

The global Vutrisiran market is expected to grow at a CAGR of 12.0% from 2026 to 2035 to reach $1.18 billion by 2035.

Some Key Players in the Vutrisiran market Include, Alnylam Pharmaceuticals Inc .

Major trend in this market includes: Expansion Into Cardiomyopathy Through FDA Approval Drives Growth in the Vutrisiran Market . For further insights on this market. request a sample here

North America was the largest region in the vutrisiran market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vutrisiran market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us